RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
暂无分享,去创建一个
S. Rosenkranz | P. Corris | H. Ghofrani | R. Benza | R. Naeije | G. Simonneau | M. Hoeper | C. Vizza | L. Scelsi | E. Grünig | D. Langleben | J. Klinger | P. Jansa | C. Meier | P. Colorado | D. Busse | Mikyung Chang